OTCPK:ICCO

Stock Analysis Report

Executive Summary

InterCare DX, Inc. operates as a biomedical and other software products development and services company.

Snowflake

Fundamentals

Adequate balance sheet with weak fundamentals.

Risks

  • InterCare DX's last earnings update was 4323 days ago.
  • InterCare DX is not covered by any analysts.

Share Price & News

How has InterCare DX's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

ICCO

-0.04%

US Healthcare

-0.6%

US Market


1 Year Return

n/a

ICCO

-9.1%

US Healthcare

0.7%

US Market

No trading data on ICCO.

No trading data on ICCO.


Share holder returns

ICCOIndustryMarket
7 Day0%-0.04%-0.6%
30 Day0%1.0%2.9%
90 Dayn/a-1.5%1.3%
1 Yearn/a-7.7%-9.1%2.9%0.7%
3 Yearn/a29.6%24.3%44.6%35.2%
5 Year138.1%138.1%66.1%56.2%61.9%44.2%

Price Volatility Vs. Market

How volatile is InterCare DX's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is InterCare DX undervalued based on future cash flows and its price relative to the stock market?


In this section, we usually try to help investors determine whether InterCare DX is trading at an attractive price based on the cash flow it is expected to produce in the future. But as InterCare DX has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Examine InterCare DX's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through InterCare DX regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is InterCare DX expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

11.1%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as InterCare DX has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has InterCare DX performed over the past 5 years?

0.1%

Historical Healthcare annual earnings growth


In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, InterCare DX has not provided sufficient past data to assess its track record.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.


Next Steps

Financial Health

How is InterCare DX's financial position?


In this section we usually analyse InterCare DX's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. InterCare DX has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.


Next Steps

  • Take a look at our analysis of ICCO’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • Investors tend to look at the financial health of a company this size in order to assess the sustainability of its current operations. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website.
  • Financial health is measured at one point in time, so the latest financial report is the best representation of the company’s current financial status. Check when InterCare DX's financial data was last updated here.
  • Explore more healthy companies in the Healthcare industry.

Dividend

What is InterCare DX's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate InterCare DX's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate InterCare DX's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as InterCare DX has not reported any payouts.

Unable to verify if InterCare DX's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as InterCare DX has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of InterCare DX's salary, the management and board of directors tenure and is there insider trading?

15.6yrs

Average management tenure


CEO

Anthony Dike (64yo)

28.7yrs

Tenure

0

Dr. Anthony C. Dike, M.D., FACP founded Intercare Dx Inc. (formerly InterCare.com Inc.) and serves as its Chief Financial Officer, Secretary and Treasurer. Dr. Dike has been the Chief Executive Officer and ...


Management Age and Tenure

15.6yrs

Average Tenure

66yo

Average Age

The average tenure for the InterCare DX management team is over 5 years, this suggests they are a seasoned and experienced team.


Insider Trading

No 3 month open market individual insider trading information.


Management Team

  • Don Stanford (68yo)

    Chief Technical Strategist and Director

    • Tenure: 14.8yrs
  • Russ Lyon (70yo)

    Chief Technology Officer

    • Tenure: 0yrs
    • Compensation: US$200.00k
  • Anthony Dike (64yo)

    Founder

    • Tenure: 28.7yrs
  • Jerry Miller (63yo)

    Interim President and Interim Chief Operations Officer

    • Tenure: 15.6yrs
  • David Butler

    Product Manager and Director of Business Development

    • Tenure: 0yrs
    • Compensation: US$45.00k
  • Mahroof Mohideen

    Senior Vice President of Europe & Gulf Region

    • Tenure: 14.5yrs
  • Kenneth Johnson

    Vice President of Business Development and Vice President of Finance

    • Tenure: 0yrs

Board Members

  • Don Stanford (68yo)

    Chief Technical Strategist and Director

    • Tenure: 14.8yrs
  • Jude Uwaezuoke (74yo)

    Director

    • Tenure: 0yrs
  • Wesley Bradford (78yo)

    Director and Member of the Clinical Advisory Board

    • Tenure: 0yrs
  • Anthony Dike (64yo)

    Founder

    • Tenure: 28.7yrs
  • Wignes Warren

    Member of the Clinical Advisory Board

    • Tenure: 0yrs
  • Jeff Raines

    Chairman of Clinical Advisory Advisory Board

    • Tenure: 0yrs

Company Information

InterCare DX, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: InterCare DX, Inc.
  • Ticker: ICCO
  • Exchange: OTCPK
  • Founded: 1991
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: US$743.039k
  • Shares outstanding: 74.30m
  • Website: https://www.intercare.com

Number of Employees


Location

  • InterCare DX, Inc.
  • 4477 West 118th Street
  • Suite 304
  • Hawthorne
  • California
  • 90250
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ICCOOTCPK (Pink Sheets LLC)YesCommon StockUSUSDSep 2002

Biography

InterCare DX, Inc. operates as a biomedical and other software products development and services company. It creates, publishes, and markets software products that are embedded with sound, text, and video  ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/21 23:41
End of Day Share Price2019/09/04 00:00
Earnings2007/09/30
Annual Earnings2006/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.